Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 6 | 1 | 7 |
| 1994 | 10 | 2 | 12 |
| 1995 | 20 | 3 | 23 |
| 1996 | 22 | 1 | 23 |
| 1997 | 18 | 3 | 21 |
| 1998 | 6 | 4 | 10 |
| 1999 | 5 | 1 | 6 |
| 2000 | 25 | 6 | 31 |
| 2001 | 11 | 4 | 15 |
| 2002 | 17 | 5 | 22 |
| 2003 | 7 | 6 | 13 |
| 2004 | 21 | 5 | 26 |
| 2005 | 24 | 4 | 28 |
| 2006 | 27 | 4 | 31 |
| 2007 | 19 | 6 | 25 |
| 2008 | 25 | 8 | 33 |
| 2009 | 17 | 9 | 26 |
| 2010 | 22 | 5 | 27 |
| 2011 | 31 | 10 | 41 |
| 2012 | 27 | 6 | 33 |
| 2013 | 32 | 4 | 36 |
| 2014 | 44 | 6 | 50 |
| 2015 | 29 | 4 | 33 |
| 2016 | 41 | 4 | 45 |
| 2017 | 24 | 6 | 30 |
| 2018 | 35 | 7 | 42 |
| 2019 | 38 | 3 | 41 |
| 2020 | 31 | 7 | 38 |
| 2021 | 47 | 5 | 52 |
| 2022 | 65 | 0 | 65 |
| 2023 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders. PLoS One. 2023; 18(3):e0282271.
-
Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY). Diabetes Care. 2023 Mar 01; 46(3):608-612.
-
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study. Nephrol Dial Transplant. 2023 02 13; 38(2):372-383.
-
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 02; 9(2):183-191.
-
Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment. Pediatr Ann. 2023 Feb; 52(2):e62-e67.
-
A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes. Nat Metab. 2023 02; 5(2):237-247.
-
High Plasma Levels of Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity. J Am Heart Assoc. 2023 02 07; 12(3):e8145.
-
Palmitoylation couples insulin hypersecretion with ? cell failure in diabetes. Cell Metab. 2023 Feb 07; 35(2):332-344.e7.
-
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease. Eur Heart J Cardiovasc Pharmacother. 2022 12 15; 9(1):85-93.
-
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes. J Hypertens. 2023 02 01; 41(2):295-302.